Mechanistic target of rapamycin complex 1 (mTORC1)-mediated phosphorylation is governed by competition between

Michael D Dennis1, Scot R Kimball, Leonard S Jefferson

  • 1Department of Cellular and Molecular Physiology, The Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033, USA.

Insights

Loss of 4E-BP1 and 4E-BP2 proteins enhances mTORC1-mediated phosphorylation of p70S6K1. This occurs because 4E-BP proteins normally compete with p70S6K1 for binding to raptor, a component of mTORC1.

Area of Science:

  • Cellular signaling pathways
  • Molecular biology
  • Biochemistry

Background:

  • The mechanistic target of rapamycin complex 1 (mTORC1) is a key regulator of cell growth and metabolism.
  • 4E-binding proteins (4E-BPs) are known inhibitors of cap-dependent translation by binding to eukaryotic initiation factor 4E (eIF4E).
  • p70S6 kinase 1 (p70S6K1) is a major downstream target of mTORC1, involved in cell growth and proliferation.

Purpose of the Study:

  • To investigate the role of 4E-BP1 and 4E-BP2 in regulating mTORC1 activity and its downstream targets.
  • To elucidate the mechanism by which 4E-BP proteins influence p70S6K1 phosphorylation.
  • To determine the impact of 4E-BP loss on the interaction between mTORC1, p70S6K1, and raptor.

Main Methods:

  • Gene disruption of 4E-BP1 and 4E-BP2 in mouse liver and embryonic fibroblasts.
  • Analysis of p70S6K1 phosphorylation levels using Western blotting.
  • Immunoprecipitation assays to study protein-protein interactions (mTORC1, raptor, p70S6K1, 4E-BP1).
  • Cotransfection experiments in cell culture systems.

Main Results:

  • Combined genetic deletion of 4E-BP1 and 4E-BP2 led to dramatically elevated p70S6K1 phosphorylation in mouse liver following feeding-induced mTORC1 activation.
  • Loss of 4E-BP1 and 4E-BP2 resulted in increased interaction between p70S6K1 and raptor, a component of mTORC1.
  • In cell culture, absence of 4E-BP1/2 enhanced p70S6K1 interaction with IGF1-activated mTORC1 and increased p70S6K1 phosphorylation at Thr-389.
  • Overexpression of 4E-BP1, but not a non-binding mutant, reduced mTORC1 recovery in HA-p70S6K1 immunoprecipitates.

Conclusions:

  • The findings indicate that 4E-BP proteins act as negative regulators of mTORC1-mediated p70S6K1 phosphorylation.
  • The absence of 4E-BP proteins leads to increased p70S6K1 phosphorylation due to reduced competition for binding to raptor.
  • This study reveals a novel mechanism of mTORC1 regulation involving substrate competition for raptor.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...